The purpose of this national diagnosis and treatment protocol (PNDS) is to outline to health providers the optimum management and integrated care pathway for patients with long-term conditions (ALD), particularly with status ALD 11: xeroderma pigmentosum (XP).
See also
HAS opinions and decisions
17/06/2009
eNq1mNty2jAQhu95Co8veofNIWBobTItTVpmkiklYdrpDSPsNYjakqsDkD59ZQwT0rFzEOgSy95d7/769GP/cpsm1hoYx5QEdtNp2BaQkEaYLAJ7en9d79mXg5q/Qmt0dJvnNJxmy7bCBHEe2PmqMwdEuPPz9uYzqOeB2YOa5dP5CkLx5D4pcOJ8RXx5i7L8HstfUxxZKYgljQI7k2J31fK5YKqKwYay3zxDIfju/srx6mp2cXzdd/Ngr4gqObAbRBalQYFoxQwlY0DEEAlYUPZQGjpjUXPW6vf63QtPKwnmE+BUshDGSCzHjK5xBFFprhglHLSSxJvoDtg6AZEnKQ3ursKUawVHK7SdwJ9RedEf1epQbEW9UW96Xq/rea12o9XqaKViR60ql496CTecdTrdfq/hAnG3wHLxpqie4UWqpkm5TDUHNaZMoMTQiDAfPpWboTwM/rwohQjzLEEPzopnuq1CDKllYAoK5l4kf4N7pjCVqJ79F5/IJHHfWPV0DxFDFeeMGlJJRAVLrie6jRhSImBbPVE9/IntXosY+PnC/qWkHP1jOU9wqMs3RSAJXEwno2q8GSPDJ8Rhysyh4QcmEd3w8yPneMSGqs921Hz28Ow2Ox3tHfVL6ani7LmSjGbgKhhhfgpjRiSmp9JFSbQ81EGgZrS580U0RAlUOKO6JnWUKA9GzpjszW2pYqE06Jere12tfJfAHu52P0tD4yg4TFmPyCYwr4T5Ut3FFg6yWbvR6fXbF+9Qmn04OO5A010XQZ8113E4a/W8ttfXa5dk5dhZCpHx96672WycJeJ1jlRbnZi98oy4LG3HOVqigPw4YXN/BYy4hcI9FTA2VPq8OGXfNlPdvfySnzjVI++f33vx0hyCSThhFgX2jcF5dHV+3j8aZGNlj59gx1yanZlFAlNiylfJeWnEk04YNVZyzRQfvsUxrvhEUylL3y0+Dw1qvpt/GhrU/gHzsxpM
r5LjR3N8nAFFAU0X
